Skip to content
Search

Latest Stories

OPINION: Rise of rogue e-pharmacies

Rich Quelch discusses a surge of unverified e-commerce pharmacies, their risk to the consumer and an urgent need for better policing of online marketplaces…

The pharmaceutical e-commerce space has been steadily growing for years, with the global e-pharmacy market forecasted to reach $177 billion globally by 2026.


Its steady growth can be attributed to changing consumer preferences following pandemic shifts in how we access healthcare and shop, greater buy-in from governments and health leaders, and new technologies making it even easier to purchase health and wellbeing products online – whether prescribed or not.

But while the legitimate e-pharmacy industry has the potential to widen access to life-changing medicines, cut administration costs, increase speed and lead to better health outcomes, its growth is mirrored by a shadow market of unverified and unsafe online pharmacy businesses.

According to the National Association of Boards of Pharmacy (NABP), 95 percent of the approximately 35,000 global online pharmacies are unregulated and rogue.

So, what does this mean for the public and the growth of the legitimate e-pharmacy market?

The rise of online pharmacies

Just like most other areas of retail, there is an increasing demand for digital services as consumers expect fast responses, high-quality service and lower costs all from the comfort of their own homes.

The same is true for buying medication and wellness products like vitamins and supplements. The pharmaceutical e-commerce space has been developing and maturing for years, but it saw the most significant growth during the pandemic.

The heightened awareness of health combined with a strained NHS only exacerbated demand for digitised pharmacies, particularly for those with medical needs who were forced to self-isolate, making accessing medication all the more difficult.

Now, e-commerce pharmacies are here to stay. But, despite the many benefits online pharmacies bring, unregulated rogue pharmacies are also increasing at a parallel rate.

The prevalence of unverified e-pharmacies

While the e-pharmacy industry is helping people gain access to quicker and more convenient healthcare, there has been a surge of unverified e-pharmacies selling potentially dangerous pharmaceutical products. This is threatening to undermine the growth and reputation of the legitimate online pharmacy sector.

The data analysts used the Screaming Frog SEO Spider and Ahref’s API tool to study 9,987 sites from the National Association of Boards of Pharmacy’s ‘not recommended list’ of e-pharmacies – sites that are unverified and therefore potentially unsafe.

The ‘fake’ e-pharmacies studied receive an estimated 1,716,667 visits globally every month and rank on the first page of Google for 32,436 different medical and health-related search terms.

Appearing on the first page of Google is usually a signal that a website can be trusted. But the study shows unverified e-pharmacies selling potentially dangerous pharmaceutical products are taking over search engine results and undermining the growth of the legitimate e-pharmacy industry.

What’s more, Origin found these ‘fake’ pharmacies had over half a million referring domains – the number of other websites linking directly to them. This means people can unsuspectingly find themselves going from a trusted website to a potentially dangerous one with just a click.

Of the external websites linking to these unverified e-pharmacies, 100,000 came from government sites and nearly 900,000 from education websites such as ‘.edu’ and ‘.ac.uk’ which are often highly trusted by both the general public and Google itself.

This is particularly concerning given that having a high number of external links back to a website can help it rank better in the Google search results, making it seem more trustworthy to the ordinary person and more likely to be featured on page one.

The risk to consumers

Buying from an unregistered online pharmacy can be dangerous for several reasons.

The effectiveness of the medication will vary greatly since their expiration dates may have been tampered with. Alternatively, they could have too high or too low a dosage of their active ingredient.

Most importantly, medicines sold on these sites are not regulated, so consumers can never know for sure what they are ingesting. In some cases, they could contain harmful or toxic substances which may be life threatening, with the World Health Organisation predicting counterfeit medicines and equipment will kill a million people every year.

Consumers may also suffer from financial loss. It’s not uncommon for consumers to not receive the medication they paid for but, more alarmingly, some fraudulent sites may sell sensitive payment information to other criminals which could lead to greater money woes.

The future of legitimate online pharmacies

Not only do these rogue pharmacy sites take business away from legitimate ones, the risk to consumers could also cause substantial damage to public perception of pharmaceutical e-commerce and may dissuade users, particularly those that are vulnerable or less the-savvy, from taking advantage of an otherwise beneficial service.

The best and most effective way to protect the reputation of e-pharmacies and guarantee their longevity is to educate consumers on how to protect themselves and spot rogue pharmacies.

Consumers should be advised against using any pharmaceutical websites that do not provide contact details licensing or certification details, charge a customs fee, spam email inboxes with offers, bulk sell medicines excessively and sell prescription-only medication without a consultation or prescription.

Highlighting the General Pharmaceutical Council (GPhC) internet pharmacy logo present on the website is another way to give consumers assurance the website is run by a registered pharmacy.

However, the primary route of change will need to come from government authorities. Last year, the UK government seized over 3 million medicines and devices from illegally operating websites valued at more than £9 million as part of an operation with Interpol.

There is an urgent need for policy decisions that are aimed at addressing fake medicines found on online pharmacies, such as the power to suspend and close down offending domain names, greater legislation on social media platforms to provide liability and transparency and better policing of online marketplaces to help prevent sales of counterfeit pharmaceutical and wellbeing goods.

Rich Quelch is global head of marketing at Origin.

More For You

Moving to hub and spoke takes an average of 80% of original pack repeat dispensing volumes out of pharmacy stores.

Time to push ahead with model one hub and spoke legislation

Moving to hub and spoke takes an average of 80% of original pack repeat dispensing volumes out of pharmacy stores. Louise Laban emphasises the benefits of this model

Centred Solutions has been at the forefront of the pharmacy hub and spoke dispensing in England over the last few years. We have already demonstrated that hub and spoke dispensing is a realistic model of dispensing for pharmacy groups of all sizes. We’ve seen the massive difference that hub and spoke can make to community pharmacy. With pharmacies struggling to survive, the time has come to stop delaying and to now push ahead with model one of hub and spoke dispensing.

In our experience, there is no risk with moving ahead with model one of hub and spoke legislation which would allow medicines to be returned from the hub to the pharmacy ready to be dispensed to the patient. We do however understand the need for more policy discussion around the second model of hub and spoke, where the hub sends the medication directly to the patient. This should not delay the implementation of model one. This model would immediately level the playing field for smaller and independent pharmacies, allowing them to use a hub and spoke model of their choice now to create capacity for clinical services. We feel strongly about this issue and that’s why we are working alongside HubRx and PillTime to raise awareness.

Keep ReadingShow less

Delivery Plan is a small step in the right direction – but community pharmacy needs a giant leap

By Malcolm Harrison

The Delivery Plan for Recovering Access to Primary Care was undeniably a vote of confidence in the sector. Whilst the plan was positioned as a package of measures to end the 8am GP scramble, the major announcements within the plan focused on community pharmacy.

Keep ReadingShow less

Self-Care: A solution for an overwhelmed health industry?

We must ensure that community pharmacists are recognised as self-care experts so that people turn to them as a first port of call, writes Bas Vorsteveld

Over the last few years, we’ve seen the aftermath of Covid-19, with the demand for consumer health products being unprecedented and unpredictable, placing pressure on supply chains and labour market. In turn, the industry has experienced acute shortages across the healthcare sector, placing huge pressure on pharmacists, doctors, nurses, and other healthcare professionals.

Keep ReadingShow less

TECHNOLOGY: Why invest in automation?

 By Cyrus Hodivala

Community pharmacies are located within the very hotspots of peoples’ communities, yet a staggering 720 individual businesses have stopped trading since 2015.  It has been called a “national disgrace and a betrayal to the elderly and the vulnerable” by sector leaders.

Keep ReadingShow less

AUTOMATION AND TECHNOLOGY: Pushing boundaries, taking risks

By James Tibbs

Our Totton branch has an incredibly high volume of original pack dispensing, roughly 45,000 items. As we became busier and busier in the dispensary we were finding that our  pharmacists, dispensers and other technicians simply didn’t have capacity to deliver the services that we needed them to.

Keep ReadingShow less